ArticleGut pathogens2025
Tripartite interplay: immune reconstitution dynamics in AIDS, gut microbiota, and Helicobacter pylori infection: current advances and therapeutic prospects.
Article in Gut pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Helicobacter pylori infection carrying the CagA gene may be associated with the diagnosis and disease progression of tuberculosis.BMC infectious diseases · 2026Article
- Review of Peptic Ulcer Disease: Insights from Pathophysiology, Mechanisms, Pharmacotherapy, Phytotherapy, and Case Reports.Drug design, development and therapy · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe immune recovery process in Acquired Immune Deficiency Syndrome (AIDS) is complex and influenced by numerous factors. Gut microbiota and their metabolites play a critical role in maintaining immune homeostasis. Additionally, the presence of Helicobacter pylori in the stomach can affect immune reconstitution in human immunodeficiency virus (HIV)/AIDS patients, either directly or through interactions with the gut microbiota.
methodsThis review adopts a comprehensive literature review approach. It systematically examines a wide range of relevant studies focusing on the interplay between HIV/AIDS immune reconstitution, gut microbiota, and H. pylori.
resultsThe review reveals intricate relationships among these components. Gut microbiota and their metabolites are essential for sustaining immune balance. H. pylori influences immune reconstitution in HIV/AIDS patients through various mechanisms, including inducing gut microbiota dysbiosis, altering gastric pH, promoting systemic inflammation, and acting synergistically with HIV. These effects can exacerbate CD4⁺ T cell depletion and may contribute to incomplete immune recovery by disrupting gut microbiota composition.
conclusionUnderstanding these interactions provides a foundation for future research directions. Such insights may offer new perspectives and strategies to address the clinical challenge of immunological non-response in HIV/AIDS patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.